GLP mimetics are currently widely used in the treatment of Type 2 diabetes while both physiological and pathophysiological effects on the exocrine pancreas are less clear
The third main feature of PCOS is polycystic ovaries, sometimes referred to as polycystic ovarian morphology (PCOM), which is diagnosed by ultrasound
GLP-1 receptor agonists and GIP/GLP-1 dual agonists carry a deep trial record: STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide for weight management (NEJM 2022), and SURMOUNT-OSA studied tirzepatide for obstructive sleep apnea (NEJM 2024)
Lastly, we confirmed that cells surviving 5FU treatment do not increase mtDNA content to compensate for overwhelming mtDNA release (Extended Data Fig
For example, in an experiment reported by Vittone et al., the mean 12-hour growth hormone concentrations were described as rising about 2-fold from about 1.1 0.9 g/L to roughly 2.2 1.9 g/L
What is the likely cause of his decreased GCS in view of VPA overdose